Anthony P. Mack

Insider Reports History

Entity
Individual
Location
C/O Virpax Pharmaceuticals, Inc., 1554 Paoli Pike #279, West Chester, PA
Signature
/s/ Christopher Chipman, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anthony P. Mack:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Virpax Pharmaceuticals, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock, $0.00001 par value 2.73M $3.52M $1.29 May 18, 2022 By Virpax Pharmaceuticals, LLC
Virpax Pharmaceuticals, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock, $0.00001 par value 253K $326K $1.29 May 18, 2022 Direct
Virpax Pharmaceuticals, Inc. Chief Executive Officer, Director, 10%+ Owner Stock Option (right to buy) 125K Jan 25, 2023 Direct

Insider Reports Filed by Anthony P. Mack

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRPX Virpax Pharmaceuticals, Inc. Jan 25, 2023 1 $0 4/A Feb 7, 2023 Chief Executive Officer, Director, 10%+ Owner
VRPX Virpax Pharmaceuticals, Inc. May 18, 2022 1 $102K 4 May 20, 2022 Chief Executive Officer, Director
VRPX Virpax Pharmaceuticals, Inc. Jan 31, 2022 1 $0 4/A Feb 25, 2022 Chief Executive Officer, Director, 10%+ Owner
VRPX Virpax Pharmaceuticals, Inc. Nov 18, 2021 1 $100K 4 Nov 22, 2021 Chief Executive Officer, Director, 10%+ Owner